Adverse events surpassed risk reduction in Pfizer and Moderna trials – new analysis.
Reanalysis of clinical phase 3 trials for COVID shots: Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials, Fraiman, September 2022.
Watch investigative reporter Jeffrey Jaxen break it down.